Mutated DNA Restored to Normal in Gene Therapy Advance
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
BioSpace9d
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Business Wire9d
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
--(BUSINESS WIRE)--Genentech, a member of the Roche Group ... respiratory tract infections including infections of the lungs, cold symptoms, and pain or swelling of the nose or throat viral ...